Endocrinology and Metabolism Research
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of endocrinology and metabolism. Papers aiming to uncover molecular and cellular mechanisms in endocrinology and metabolism are welcome. Topics include but are not limited to gene regulation, cell biology, signaling, mutations, growth factors, cytokines, hormone receptors, hormone action and regulation, developmental endocrinology, genetic endocrinology, endocrine diseases (diabetes, obesity, osteoporosis, hyperthyroidism etc.), and metabolic diseases.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Diabetes: Comorbidities, Therapeutics and Insights (Deadline: 30 September 2023)
- New Diagnostic and Therapeutic Approaches in Diabetic Microvascular Complications (Deadline: 30 September 2023)
- Polycystic Ovary Syndrome (PCOS): Genetic, Hormonal and Metabolic Aspects (Deadline: 30 September 2023)
- Metabolic Syndrome: From Target Molecules to Therapeutic Approaches (Deadline: 30 September 2023)
- 10th Anniversary of Biomedicines—Advances in Endothelial Dysfunction (Deadline: 31 October 2023)
- Recent Advances in Obesity and Hypertension (Deadline: 31 October 2023)
- Molecular Research in Obesity (Deadline: 31 October 2023)
- Molecular Research on Polycystic Ovary Syndrome (PCOS) 2.0 (Deadline: 31 October 2023)
- Peripheral Artery Disease and Diabetic Foot Ulcer: From Bench to Clinic (Deadline: 31 October 2023)
- Endocrine Disorders: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 October 2023)
- Emerging Trends in Lipoprotein and Cardiovascular Diseases (Deadline: 31 October 2023)
- Sphingolipid Metabolism and Signaling in Health and Diseases (Deadline: 15 November 2023)
- mRNA Metabolism in Health and Disease 2.0 (Deadline: 30 November 2023)
- Advances in Polycystic Ovary Syndrome Research: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 30 November 2023)
- Hormones in Muscle and Bone Diseases: Focus on Myokines (Deadline: 30 November 2023)
- Macrophages in Cardio-Renal Diseases (Deadline: 30 November 2023)
- Genetics, Obesity, Diabetes and Metabolic Syndrome (Deadline: 30 November 2023)
- Advances in Mechanism Research of Diabetes and Insulin Resistance (Deadline: 30 November 2023)
- Glucose Metabolism: Molecular Basis and Novel Therapies of Diabetic Complication (Deadline: 31 December 2023)
- Advances in Fatty Acid Metabolism as the Markers of Civilization Diseases 2.0 (Deadline: 31 December 2023)
- Metabolic- and Genetic-Associated Fatty Liver Diseases Volume II (Deadline: 31 December 2023)
- Advanced Research in Metabolic Syndrome (Deadline: 31 December 2023)
- Advances in Iron Deficiency and Iron-Related Disorders (Deadline: 31 January 2024)
- Major Breakthroughs in Diabetic Animal Model Research (Deadline: 31 January 2024)
- Metabolic Syndrome from the Perspectives of Genetics, Genomics and Proteomics (Deadline: 31 January 2024)
- Molecular and Cellular Mechanisms of CVD: Focus on Atherosclerosis Volume II (Deadline: 31 January 2024)
- Recent Advances in Obesity-Related Metabolic Diseases (Deadline: 31 January 2024)
- State-of-the-Art Endocrinology and Metabolism Research in Poland Volume II (Deadline: 31 January 2024)
- Advances in Endothelial Signaling and Function in Diabetes (Deadline: 31 January 2024)
- Vitamin K and Vitamin D in Health and Disease (Deadline: 29 February 2024)
- The Role of Telomere and Telomerase in Human Disease (Deadline: 29 February 2024)
- Diabetes and Complications of Diabetes: Pathophysiology, Mechanisms, and Therapies (Deadline: 31 March 2024)
- Fatty Liver Disease: From Mechanisms to Therapeutic Approaches (Deadline: 31 March 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
